Astrea Bioseparations acquires Delta Precision
Astrea Bioseparations – a UK provider of bioseparation and purification technologies headquartered in Cambridge – says the acquisition will allow it to expand its product offering to include a full range of high-performance chromatography columns for biomanufacturing, complementing and strengthening the company’s existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns.
The two companies have enjoyed a long-standing relationship for almost a decade, with Astrea championing Delta Precision’s products as ‘widely recognized for their quality, ease of use, and durability’.
Delta - which is based in Gloucester - produces products for a variety of applications, including protein purification, vaccine production, and drug development.
“We are delighted to welcome the Delta team into the fold. The acquisition of Delta is another step forward in Astrea Bio’s rapid expansion to support the biopharmaceutical manufacturing field,” said Terry Pizzie, CEO of Astrea Bio. “This is a highly strategic move for us, allowing us to offer a full range of industry-leading purification and separation tools.”
Geoff Parnell, Co-founder and Managing Director at Delta Precision, added: “We look forward to joining the Astrea Bio family, further cementing the long-standing relationship between the two companies. We are confident that our expertise in column manufacturing will complement and accelerate the Astrea Bio business and customer reach.”
